Securities transactions are subject to risks, in particular the risk of total loss of the invested capital. Therefore, prior to any decision for or against an investment, you should seek personal and thorough investment advice considering your personal assets and portfolio of investments; you should not base your decision for or against an investment on the information provided on this website but consider the any and all documentation and information necessary for a decision for or against an investment. For this purpose, please contact your credit and securities institutions, Deutsche Börse AG does not provide any investment advice. Legitimacy of a securities purchase may be subject to various prerequisites, particularly your citizenship; please also seek advice as to this aspect before taking a decision for or against an investment.
The information provided on this website neither constitutes investment advice nor an offer for purchase or sale or a solicitation to make an offer for purchase or sale of financial instruments or for underwriting financial instruments.
Deutsche Börse AG does not accept any liability or warranty for the information published on this website with the exception of liability for wilful misconduct or gross negligence; such information may– e. g. due to errors of third parties – be incorrect, incomplete or outdated. In particular, in case securities prospectuses are used, Deutsche Börse AG does not accept responsibility for the prospectus or liability for statements made in the prospectus and is no supplier of securities.
The securities listed hereafter are neither admitted to nor included in the Regulated Market at Frankfurter Wertpapierbörse (FWB®, the Frankfurt Stock Exchange). Private and institutional investors must be aware that the EU-harmonized high transparency requirements and stringent investor protection regulations for organized markets therefore do not apply.
After confirming that you have read and accepted the above warnings by clicking on the button „I agree“, you will get access to the desired content.
Teva Pharmaceutical Finance Netherlands II BV 4,500% 3/2025
ISIN XS1813724603 | WKN A190FK | Type Bond
|Last Price||99,9850 %|
|Change from Prev. Day||-0.77 / -0.76%|
|Date / Time||20.11.2018 / 11:39:25|
|52 week High||0.000|
|52 week Low||0.000|
|Trading Hours||08:00 - 17:30*|
Teva Pharmaceutical Finance Netherlands II BV 4,500% 3/2025 Tick Data (FSE)
No data available
|Yield in % (last price)||4,361|
|Yield in % (ask)||4,245|
|Yield in % (bid)||4,3628|
|Accrued Interest in %||0.97500|
|Accrued Interest days||-|
|Duration in years||5.489|
|Modified Duration in years||5.372|
Frankfurt Trading Parameters
|Specialist||HELLWIG WERTPAPIERHANDELSBANK GMBH|
|First Annual Pay Date||01/09/2018|
|Interest Payment Count||2,0|
|Start Interest Payment||14/03/2018|
|Name||Teva Pharmaceutical Finance Netherlands II BV 4,500% 3/2025|
|Market Segment||Open Market|
|Issuer||Teva Pharmaceutical Finance Netherlands II B.V|
|First Trading Day||14/03/2018|
|Cancellation Type||ab 01.12.2024 jederzeit zu 100%, 20 Tage Kündigugnsfrist|